{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:20:29Z","timestamp":1761920429902,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jneuroim.2018.02.013","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T04:24:44Z","timestamp":1519791884000},"page":"97-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder"],"prefix":"10.1016","volume":"318","author":[{"given":"Marco","family":"Bo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Niegowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giannina","family":"Arru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Mariotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Mancinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Farinazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Gajofatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruggero","family":"Capra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3191-8597","authenticated-orcid":false,"given":"Salvatore","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GianPietro","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0566-2049","authenticated-orcid":false,"given":"Leonardo A.","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.013_bb0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.nic.2016.12.010","article-title":"Neuromyelitis optica spectrum disorders","volume":"27","author":"Akaishi","year":"2017","journal-title":"Neuroimaging Clin. N. Am."},{"issue":"3","key":"10.1016\/j.jneuroim.2018.02.013_bb0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein-Barr virus infection and multiple sclerosis: a review","volume":"5","author":"Ascherio","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"9","key":"10.1016\/j.jneuroim.2018.02.013_bb0015","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.humimm.2013.06.016","article-title":"High in vitro immune reactivity to Escherichia coli in neuromyelitis optica patients is correlated with both neurological disabilities and elevated plasma lipopolysaccharide levels","volume":"74","author":"Barros","year":"2013","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2018.02.013_bb0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic antiaquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.02.013_bb0025","article-title":"Interferon regulatory factor 5 is a potential target of autoimmune response triggered by Epstein-barr virus and Mycobacterium avium subsp. paratuberculosis in rheumatoid arthritis: investigating a mechanism of molecular mimicry","author":"Bo","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.jneuroim.2018.02.013_bb0030","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/s41598-018-19957-z","article-title":"Rheumatoid arthritis patient antibodies highly recognize IL-2 in the immune response pathway involving IRF5 and EBV antigens","volume":"8","author":"Bo","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jneuroim.2018.02.013_bb0035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2018.02.013_bb0040","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes antiaquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.013_bb0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2217\/fmb.12.135","article-title":"A Sardinian map for multiple sclerosis","volume":"8","author":"Cossu","year":"2013","journal-title":"Future Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2018.02.013_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2013.09.011","article-title":"Anti Mycobacterium avium subsp. paratuberculosis heat shock protein 70 antibodies in the sera of Sardinian patients with multiple sclerosis","volume":"335","author":"Cossu","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.jneuroim.2018.02.013_bb0055","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1177\/1352458514557304","article-title":"Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients","volume":"21","author":"Cossu","year":"2015","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jneuroim.2018.02.013_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2010.11.013","article-title":"Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases","volume":"138","author":"Di Pauli","year":"2011","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.013_bb0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.autrev.2011.08.005","article-title":"Autoimmune disease: a role for new anti-viral therapies?","volume":"11","author":"Dreyfus","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2018.02.013_bb0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.expneurol.2014.12.015","article-title":"The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passivetransfer model","volume":"265","author":"Geis","year":"2015","journal-title":"Exp. Neurol."},{"issue":"24","key":"10.1016\/j.jneuroim.2018.02.013_bb0075","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","article-title":"Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica","volume":"69","author":"Hinson","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jneuroim.2018.02.013_bb0080","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1073\/pnas.1109980108","article-title":"Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes","volume":"109","author":"Hinson","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jneuroim.2018.02.013_bb0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","article-title":"Neuromyelitis optica: passive transfer to rats by human immunoglobulin","volume":"386","author":"Kinoshita","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2018.02.013_bb0090","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.jneuroim.2018.02.013_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10875-012-9780-2","article-title":"The ex vivo production of IL-6 and IL-21 by CD4\u00fe T cells is directly associated with neurological disability in neuromyelitis optica patients","volume":"33","author":"Linhares","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2018.02.013_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2014.02.013","article-title":"Epstein\u2013Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients","volume":"270","author":"Mameli","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.02.013_bb0105","article-title":"Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients","volume":"6","author":"Mameli","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.jneuroim.2018.02.013_bb0110","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/brain\/awq177","article-title":"Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury","volume":"133","author":"Marignier","year":"2010","journal-title":"Brain J. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2018.02.013_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063371","article-title":"Zinc transporter 8 and MAP3865c homologous epitopes are recognized at T1D onset in Sardinian children","volume":"8","author":"Masala","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jneuroim.2018.02.013_bb0120","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/jnnp-2014-308095","article-title":"Epstein-Barr virus persistence and reactivation in neuromyelitis optica","volume":"86","author":"Masuda","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2018.02.013_bb0125","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jneuroim.2018.02.013_bb0130","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00401-013-1116-7","article-title":"Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica","volume":"125","author":"Misu","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.013_bb0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1055\/s-0042-124186","article-title":"Neuromyelitis optica","volume":"85","author":"Pache","year":"2017","journal-title":"Fortschritte Neurologie Psychiatrie"},{"key":"10.1016\/j.jneuroim.2018.02.013_bb0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2018.02.013_bb0145","first-page":"189096","article-title":"CD8+ T-cell deficiency, Epstein\u2013Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis","volume":"2012","author":"Pender","year":"2012","journal-title":"Autoimmune Dis."},{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.013_bb0150","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2018.02.013_bb0155","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.4049\/jimmunol.1200486","article-title":"Cross-immunoreactivity between bacterial aquaporin-Z and human aquaporin-4: potential relevance to neuromyelitis optica","volume":"189","author":"Ren","year":"2012","journal-title":"J. Immunol."},{"issue":"Pt 5","key":"10.1016\/j.jneuroim.2018.02.013_bb0160","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain J. Neurol."},{"issue":"24","key":"10.1016\/j.jneuroim.2018.02.013_bb0165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1203463109","article-title":"Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica","volume":"109","author":"Rossi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 2","key":"10.1016\/j.jneuroim.2018.02.013_bb0170","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain J. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2018.02.013_bb0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jneuroim.2009.07.014","article-title":"Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study","volume":"215","author":"Sabater","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.02.013_bb0180","article-title":"Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings","author":"Sechi","year":"2017","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.013_bb0185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-010-0704-z","article-title":"Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination","volume":"120","author":"Sharma","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.jneuroim.2018.02.013_bb0190","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jnnp-2011-300434","article-title":"Sera from neuromyelitis optica patients disrupt the blood-brain barrier","volume":"83","author":"Shimizu","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jneuroim.2018.02.013_bb0195","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/WNL.0b013e3181e2414b","article-title":"Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study","volume":"75","author":"Takano","year":"2010","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jneuroim.2018.02.013_bb0200","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","article-title":"Epstein-Barr virus in autoimmune diseases","volume":"22","author":"Toussirot","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jneuroim.2018.02.013_bb0205","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp.2011.241760","article-title":"CSF interleukin-6 level predicts recovery from neuromyelitis optica relapse","volume":"83","author":"Uzawa","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jneuroim.2018.02.013_bb0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jocn.2012.12.022","article-title":"Neuromyelitis optica: concept, immunology and treatment","volume":"21","author":"Uzawa","year":"2014","journal-title":"J Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.jneuroim.2018.02.013_bb0215","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1212\/WNL.0b013e318266fc2b","article-title":"T-cell reactivity against AQP4 in neuromyelitis optica","volume":"79","author":"Vaknin-Dembinsky","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2018.02.013_bb0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4- specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize clostridium ABC transporter","volume":"72","author":"Varrin-Doyer","year":"2012","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jneuroim.2018.02.013_bb0225","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.jneuroim.2018.02.013_bb0230","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2018.02.013_bb0235","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ana.22551","article-title":"Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818300183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818300183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:32:09Z","timestamp":1759048329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818300183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":47,"alternative-id":["S0165572818300183"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.02.013","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}